EATONTOWN, N.J., Aug. 24 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE - News) today issued the following statement in response to questions the Company has received regarding Donor Referral Services as a result of recent stories in the media.
We want to assure our customers, partners, shareholders, and employees, that Osteotech does not conduct and has never conducted business with Donor Referral Services.
Osteotech is committed to upholding the highest ethical standards and strictest screening processes to ensure the safety of all tissue processed and released by Osteotech.
Osteotech, Inc., headquartered in Eatontown, New Jersey, is a leading provider of human bone and bone connective tissue for transplantation and an innovator in the development and marketing of biomaterial and implant products for musculoskeletal surgery. For further information regarding Osteotech or this press release, please go to Osteotech’s website homepage at http://www.osteotech.com and to Osteotech’s Financial Information Request Form website page at http://www.osteotech.com/finrequest.htm.
Source: Osteotech, Inc.
